Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Zim Laboratories Ltd. ( (IN:ZIMLAB) ) just unveiled an update.
Zim Laboratories Limited has announced the closure of its trading window for company securities starting 1 January 2026, in line with SEBI (Prohibition of Insider Trading) Regulations, 2015 and its internal code of conduct for regulating, monitoring and reporting trading by insiders. The restriction applies to designated persons, including promoters, directors, key managerial personnel, connected persons, specified employees and their immediate relatives, and will remain in force until 48 hours after the company discloses its financial results for the quarter and nine months ended 31 December 2025, underscoring ongoing adherence to regulatory norms and governance standards around unpublished price-sensitive information.
More about Zim Laboratories Ltd.
Zim Laboratories Limited is an India-based pharmaceutical company engaged in the development and manufacturing of drug delivery solutions and formulations, serving domestic and international markets through its facilities in Nagpur, Maharashtra.
Average Trading Volume: 4,325
Technical Sentiment Signal: Sell
Current Market Cap: 3.34B INR
For a thorough assessment of ZIMLAB stock, go to TipRanks’ Stock Analysis page.